Talk:Solid-phase peptide synthesis
Discussion page·3 threads·1 archive
This is the discussion page for the article Solid-phase peptide synthesis. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.
Racemisation invisible to massDone
Worth the cross-link to the mass spectrometry article, where the same gap is described from the analytical side. — MassSpecMarv (talk) 10:40, 3 April 2026 (UTC)
Linked. Histidine and cysteine are the usual suspects and the article names them. ✓ Done — CouplingCillian (talk) 14:15, 3 April 2026 (UTC)
Process detail versus quality attributes
The distinction between process choices and quality attributes is worth keeping visible. Readers sometimes expect a certificate to describe a process; it describes a product. — GMP_Gita (talk) 11:05, 16 June 2026 (UTC)
Agreed, and the article says what is derivable from a certificate, which keeps the point constructive. — COA_Colwyn (talk) 14:40, 16 June 2026 (UTC)